Gabapentin and Tizanidine for Insomnia in Chronic Pain
Status:
Enrolling by invitation
Trial end date:
2023-07-29
Target enrollment:
Participant gender:
Summary
This is a double-blind, placebo-controlled, randomized, crossover trial aimed at assessing
the effect of gabapentin and tizanidine, two pain medications, on insomnia in chronic pain
patients.
Phase:
Phase 2
Details
Lead Sponsor:
University of California, San Diego
Collaborator:
National Center for Advancing Translational Science (NCATS)